NET PROFIT (x1000 EUR)
EMPLOYEES
Biocreative AB
Closing information (x1000 EUR)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
5
|
9 |
| Earnings before taxes |
-2
|
1
|
-2 |
| EBITDA |
-6
|
-4
|
-6 |
| Total assets |
134
|
131
|
142 |
| Current assets |
13
|
15
|
44 |
| Current liabilities |
112
|
108
|
116 |
| Equity capital |
21
|
22
|
24 |
| - share capital |
9
|
8
|
9 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
15.7%
|
16.8%
|
16.9% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-1.5%
|
4.6%
|
4.9% |
| Current ratio |
11.6%
|
13.9%
|
37.9% |
| Return on equity (ROE) |
-9.5%
|
4.5%
|
-8.3% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.